RE:I figured no pumper would answer question re why they
Because they want to sell the company once ryplazim is approved. This is their priority and moreover extra expense for what?? You very well know the answer buddy. Everyone here knows what Thomvest wants to do. Thomvest has a history of lifting dead buisnesses and selling them for good price after. They are not entrepreneurs but traders. This will be sold once ryplazim is approved. No.more studies no more stupidty. Simple buisness here. This company is worth atleast 2Billion in near term and 1 Billion in worst case. Once they have sales, and pipeline products are amazing and patents are also valuable. Anyone can buy fhis company with consitant sales that take cares of further study and operations with some positive cash flow. Honestly Edorse dont act like idiot here. The new owners will hire scientists to run all halted programmes. This is plain n simple with Liminal. Invest or short ,thats your theory, But you wont see existance of this company in a year.